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Introduction
Homozygous sickle cell disease (SCD) is an autosomal reces-
sive inherited hemoglobinopathy generating hemoglobin SS
(HbS). The prevalence is 5% of the world population with the
highest frequency in India, Middle East, South Europe, and
among Afro-Caribbean population.1 Hypothermia, hypoxia,
acidosis, or low-ﬂow states are conditions causing deforma-
tion to the characteristic sickle shape, increasing the risk
of hemolysis, vaso-occlusion and subsequent end-organ
damage.2 Cardiopulmonary bypass (CPB) use in multimor-
bide patients carries an increased risk of a sickling crisis
requiring special perioperative management.
Case Description
A45-year-oldblackAfricanmantreatedwithhydroxycarbamid
due to SCD (HbS 96%: electrophoresis 1 year prior to admis-
sion)washospitalizedbecauseofa catheter-related, coagulase-
negative staphylococcal (Staphylococcus epidermidis) sepsis
and infection-induced sickle crisis. His medical history was
signiﬁcant for multiple sickle crises including GAVE (gastric
antral vascular ectasia)-syndrome, portal hypertension, trans-
fusion acquired HCV (hepatitis C virus) infection, and chronic
ulcer of the lateral malleolus. After catheter explantation, an
antimicrobial therapy with daptomycin was initiated after
reviewing the resistance proﬁle (oxacillin, ciproxin, gentamy-
cin) and weighing the pros and cons of the medication related
to the patient’s health status and renal function. Because of the
growth of multiresistant pseudomonas aeruginosa in tracheal
secretions, therapy with meropenem was added 4 days later.
Due to the sickle crisis and Hb of 7.0 g/dL, initial treatment
included hydration with a transfusion of six red blood cell
units (RBCs). During the ﬁrst days of treatment, the patient
developed acute kidney injury and cardiac decompensation.
Echocardiography demonstrated a bicuspid aortic valvewith a
vegetation attached to the raphe between left- and noncor-
onary cusp accompanied by severe regurgitation. Further
ﬁndings included signiﬁcant right ventricle (RV) dilatation
with severe tricuspid regurgitation, pulmonary hypertension
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(RV/RA (right atrium)-gradient 41 mm Hg) and a left ventri-
cular ejection fraction of 54%. After the diagnosis of active
endocarditis, the antimicrobial therapy was changed from
daptomycin to vancomycin, still accompanied with merope-
nem for the resistant pseudomonas. The preoperative therapy
included positive inotropic support and continuous hemodia-
ﬁltration due to acute renal failure and metabolic acidosis.
Additional transfusionof twoRBCsbefore surgery reducedHbS
to 5.4%.
Anesthesia was induced with propofol, ketamine, fenta-
nyl, and rocuronium and was maintained with sevoﬂurane
and remifentanil. During CPB, sevoﬂuranewas replacedwith
propofol. Ventilationwas controlledwith amixture of air and
oxygen (FiO2 ¼ 0.6) and the end tidal carbon dioxide con-
centration was maintained between 4.0 and 5.0 kPa. The
double-valve procedure was performed through median
sternotomy with a routine aortic and bicaval cannulation.
A heparin-coated open bypass circuit (Carmeda Medical
Tubing, Medtronic, Brooklyn Park, Minnesota, United States),
a hard-shell venous reservoir, a hollow ﬁber membrane
oxygenator (Afﬁnity Fusion with Carmeda Bioactive Surface,
Medtronic, Brooklyn Park) with integrated polyester arterial
line ﬁlter (40 mm pore size), and an arterial roller pump
(Stockert S5, Sorin Group, Germany)were installed. Standard
CPB priming was used, consisting of Ringer’s lactate, hepar-
ine, tranexamic, acid and mannitol. Because of antithrombin
III deﬁciency, 1,000 U of antithrombin and three RBCs were
added. The ﬂow rate was kept high at approximately 120%
(100% ¼ 4.49 Lpm) to maintain venous oxygen saturations
between 80 and 85%. Anticoagulation was performed
according to standard protocol (heparine 300 U/kg, ACT
[anti-clotting time] > 350 seconds). Perfusion pressure
was kept above 70 mm Hg. Crystalloid cardioplegia was
applied and aspirated immediately through sinus coronarius.
Normothermia was maintained throughout the operation.
During continous ultraﬁltration to counteract hemodilution,
the uncoated hemoﬁlter (BC140 plus, Maquet Cardiopul-
monary GmbH, Rastatt, Germany) had to be exchanged
twice because of coagulation. After resection of the vegeta-
tion, the aortic valve was replaced (25 mm porcine prosthe-
sis, Mosaic Ultra, Medtronic). The ventriculoarterial portion
was reconstructed with a pericardial patch (►Fig. 1a and b).
Dilated tricuspid annulus was reconstructed with a 32 mm
Tri-Ad Adams tricuspid annuloplasty ring (Medtronic). After
92 minutes of aortic clamping and 20minutes of reperfusion
the patient was weaned from CPB easily. Exsanguinated
blood in the oxygenator was discarded and not transfused.
Additional eight RBCs were administrated peripherally
through level 1 infuser without pressure. Intraoperative
coagulation was optimized in accordance to thromboelasto-
graphywith 2  250mL single donor thrombocytes and four
fresh frozen plasma. Negative-balance hemoﬁltration was
continued after surgery to remove excessive ﬂuid loading
and to reverse high potassium. No autologous cell-saver was
used. (►Table 1: perioperative SCD-checklist)
On ICU, the patient was pharmacologically supported,
kept warm with a warming blanket and extubated 8 hours
postoperatively. Supplemental oxygen was given to keep
oxygen saturation > 95%. Gentamycin was added at the
day of operation but the blood samples were repeatedly
tested to be resistant and ﬁnally gentamycin was terminated
after 3 days. Rifampicin was initiated at the postoperative
day 3. Same day, meropenem was stopped and vancomycin
was changed to Daptomycin after receiving negative samples
of the explanted tissue and native valve with respect to the
clinical status and renal function of the patient.
Fig. 1 (a) Aortic annulus after patch reconstruction of the ventriculoarterial portion (); (b) the epicardium shows structural rough bearings of
the surface.
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The hemodiaﬁltration was stopped 10 days after the sur-
gery. Thepatientwasdischargedafter 13dayspostoperatively.
Three months of follow-up demonstrated correct valve func-
tion and signiﬁcant improvement of the clinical condition.
Discussion
Although SCD is an unusual hemoglobinopathy in the
European population, it gains a growing importance due to
the global migration process. Perioperative management
should minimize potential sickling agents that may lead to
deformation resulting in anemia, small-vessel occlusion, and
organ damage.2–4
General hematologists’ advice includes a reduction of the
HbS level to an average of 5% before or at the time of cardiac
surgery.4 The available methods include homologous trans-
fusion, autotransfusion and partial exchange. Exchange
transfusions do not alter the hematocrit or viscosity but
replace sickle cells with normal erythrocytes and suppress
further HbS production. Simple transfusion expands the
normal red cell mass thereby improving oxygen delivery at
the cost of increasing blood viscosity. Autologous transfusion
with the use of cell-saver systems on the one hand, reduce
the need forhomologous blood transfusion but alsomake the
ﬁltered blood more prone to sickling.5 Despite well-known
transfusion-related complications, simple blood transfusion
seems to be beneﬁcial also in case of Hb levels > 7 g/dL.6
Although many clinical reports indicate preoperative
exchange transfusion as the method of choice, there are
also cases of successful intraoperative transfusions using
blood for circuit priming.5,6 As discussed in the recent over-
view of Crawford et al the standard recommendation on
preoperative exchange transfusions is changing by gaining a
wider focus on the negative aspects, that is, association of
large volume transfusions and coagulopathy, culminating
free iron, and free radical organ damage. All in all, there is
no randomized study that supports strongly one of both
methods. There might be a tendency to a more conservative
transfusion approach targeting a preoperative level > 10 g/dL
than a HbS fraction < 30% reporting similar surgical
outcomes.7 In our anemic patient, pre- and intraoperative
transfusions were chosen as the most adequate option, as the
HbS was almost 5% preoperatively after having received
cumulatively eight RBCs over a time period of 12 days because
of decreasing Hb levels due to infectious status.
In view of vasoconstriction, normothermia was described
as the most frequent option.5
There is, however, evidence that hypothermia appears in
vitro to slow polymerization of HbS and delay the sickling of
the RBCs.5 Few papers report intraoperative hypothermia as
a successful method in SCD patients undergoing CPB.8 In our
patient with acute renal injury and chronic malleolus ulcer,
we chose normothermia to avoid vasoconstriction and
sequential complications.
Focusing on cardioplegia, described methods include
warm blood or crystalloid infusions and specially designated
combinations.3 Theoretically, crystalloid, cold cardioplegia
should be avoided because of the possibility of sickling and
vascular occlusion in the coronary microvasculature. Never-
theless, no negative effects concerning myocardial infarction
Table 1 Checklist for perioperative management of SCD under CPB
Hb level Body temperature
and venous stasis
Volemic status Oxygenation/
acidosis
Cardioplegia
Preoperative
treatment
Simple blood trans-
fusion, Hbs < 5%
for cardiac surgery
(< 30% for major
surgery)
Active warming
during induction
with FAWs
Normovolemia with
perioperative ﬂuid
balance
Balanced metabolic
status, use of
hemoﬁltration
when needed
–
Intraoperative
management
Blood for circuit
priming, avoidance
of pressure use
during peripheral
administration of
RBCs, avoidance of
cell-saver and
retransfusion of
exsanguinated
blood from the
oxygenator
When proceeding
in normothermia:
active warming
with FAWs, under-
body conductive
heat mat, circulat-
ing water mattress,
or radiant warmer;
Avoidance of tour-
niquets and
compression
Normovolemia with
a use of simple
transfusion, ultraﬁl-
tration and hemo-
ﬁltration when
needed
Hemoﬁltration dur-
ing CPB, buffers
when needed,
Higher ﬂow rate
(120%) to maintain
venous oxygen
saturations
between 80 and
85%, perfusion
pressure was kept
above 70 mm Hg
Crystalloid cardio-
plegia, aspiration
through sinus
coronarius,
continuous
hemoﬁltration
during CPB
Postoperative
treatment
According to clini-
cal manifestations
(i.e., additional
transfusions)
Active warming
with FAWs, posi-
tioning on ICU
Negative-balance
hemoﬁltration to
remove excessive
ﬂuid loading
Balanced metabolic
status, use of
hemoﬁltration
when needed, pulse
oximetry monitor-
ing: keep
saturation > 95%
–
Abbreviations: CPB, cardiopulmonary bypass; FAWs, frequent measured and forced air warmers; Hb, hemoglobin; ICU, intensive care unit; RBCs, red
blood, cells; SCD, sickle cell disease.
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or additional inotropic support during intensive care unit
(ICU) stay have been reported.9 Removal of potassium and
cardioplegia can be provided by continuous hemoﬁltration
and aspiration through the sinus coronarius by the surgeon.
Hypoxia can be successfully avoided using venous oxygen
saturation as a reliable oxygenationmarker, with SvO2 levels
of 80%.3,5 After extubation pulse oximetry monitoring
should be continued to keep saturation > 95%. Low-ﬂow
states, hypovolemia and acidosis can be monitored and
avoided with the use of CPB and continuous hemoﬁltration.
In summary, CPB can be well tolerated after individual
adaptation of the standard protocol and avoidance of risk
factors. The preoperative exchange transfusion does not
appear to be necessary and a simple euvolemic transfusion
at the time of operation can be beneﬁcial in anemic patients.
Crystalloid cardioplegia seems to be a safe method. Multi-
disciplinary planning, taking into account all risk factors, is
required for a safe and individually adjusted therapy.
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